FRITZ FRYE: Open Payments
NPI 1124137237 · AYNOR, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 41 payments from 10 companies in 2025. Trend: 2023 $304 · 2024 $538 · 2025 $1,024
Food & beverage: $1,024
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 6 | $272 |
| AstraZeneca Pharmaceuticals LP | 14 | $263 |
| Supernus Pharmaceuticals, Inc. | 3 | $128 |
| GlaxoSmithKline, LLC. | 5 | $91 |
| Novo Nordisk Inc | 3 | $88 |
| ABBVIE INC. | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Lilly USA, LLC | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $16 |
Products named: VOQUEZNA, Qelbree, AIRSUPRA, TRELEGY ELLIPTA, FARXIGA, Wegovy, CAPLYTA, VRAYLAR.
Industry payments across SC — which companies pay providers there.
